Paper Details

  1. Home
  2. Paper Details

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study.

Author: BuseDawn C, CadyRoger, EttrupAnders, JosiassenMette Krog, LindstenAnnika, LiptonRichard B

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study examined whether a migraine prevention medication, eptinezumab, improved how well acute migraine medications worked in people with migraines. The researchers assessed the effectiveness of acute treatments after four weeks of using eptinezumab.
Paper Details　
Original Abstract of the Article :
The benefits of preventive treatment on the effectiveness of migraine management have rarely been examined. This post hoc analysis investigated the impact of eptinezumab on the optimization of acute medication effectiveness using the 4-item Migraine Treatment Optimization Questionnaire (mTOQ-4) to m...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336038/

データ提供：米国国立医学図書館（NLM）

Eptinezumab: Optimizing Migraine Management

This research investigates the impact of eptinezumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP), on the optimization of acute medication use in migraine management. The study aimed to evaluate the effectiveness of eptinezumab in reducing the need for and improving the effectiveness of acute migraine medications.

Eptinezumab: A New Oasis for Migraine Relief

This study explores the role of eptinezumab in enhancing the effectiveness of acute migraine medications. Imagine a desert oasis offering respite from the scorching sun. Eptinezumab could provide a similar oasis for migraine sufferers, reducing the frequency and severity of migraines and improving the effectiveness of acute medications.

Migraine Management: Finding the Right Path

This study provides valuable insights into the impact of eptinezumab on migraine management. By reducing the need for and improving the effectiveness of acute medications, eptinezumab offers a new approach to migraine treatment. This research highlights the importance of exploring novel therapeutic options to improve the lives of individuals living with migraines.

Dr.Camel's Conclusion

This research sheds light on the potential of eptinezumab to optimize migraine management. It's like a camel navigating a treacherous desert, seeking a source of water and relief from the harsh conditions. Eptinezumab could offer a similar oasis for migraine sufferers, reducing the impact of this debilitating condition and improving their quality of life.
Date :
  1. Date Completed 2022-08-01
  2. Date Revised 2022-08-01
Further Info :

Pubmed ID

35902796

DOI: Digital Object Identifier

PMC9336038

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.